Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0040822 (tremor)
 18,428 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We report here 7 patients with episodic cluster headache belonging to three families. During follow-up, we investigated the occurrence of migraine and other disorders in the patients and their relatives. In two of the three families we recorded the occurrence of migraine and in one of these the presence of chronic daily headache, tension headache, essential tremor and cyclic depression. In the third family we detected the occurrence of systemic arterial hypertension in the father and childhood hyperkinesia in the son. We discuss the possible relations between these diseases, especially between migraine and cluster headache, and suggest a better investigation of cluster headache co-morbidity since such a study may help to further understanding of the physiopathology of the disorder.
 ...
PMID:Cluster headache: report of seven cases in three families. 943 45

The efficacy of botulinum toxin (BTX) without systemic effects has led to the rapid development of applications in neuromuscular disorders, hyperactivity of sudomotor cholinergic-mediated glandular function, and pain syndromes. The successful use of BTX in conditions with muscle overactivity, such as dystonia and spasticity, has been established and new areas in the field of movement disorders such as tics, tremor, myoclonic jerks, and stuttering has been explored with satisfactory results. Strategies to temporarily inactivate muscle function after orthopaedic or neurosurgery have also been developed. BTX treatment of hyperhidrosis was followed by its application in other hypersecretory conditions (hyperlacrimation and nasal hypersecretion) and in excessive drooling. Studies are in progress, aimed at optimising the technique and protocol of administration. Other applications for BTX have been proposed in gastroenterological and urogenital practice; it appears to be effective in replacing standard surgical procedures. Trials of BTX in painful conditions are ongoing mainly on refractory tension headache, migraine, and backache as well as dystonia-complex regional pain syndrome and myofascial pain with promising results. Recently, the fastest growing use for BTX toxin has been in the cosmetic applications. Clearly, the indications for the use of BTX are expanding, but further clinical trials will be needed in many different areas.
 ...
PMID:New therapeutic indications for botulinum toxins. 1502 69